Ardana Bioscience Trademark Details
Word Mark | Ardana Bioscience |
---|---|
Status | Dead Registered 710 — Cancelled - Section 8 |
Serial Number | 76178478 |
---|---|
Registration Number | 3147061 |
Status Date | Friday, May 3, 2013 |
Filing Date | Friday, May 3, 2013 |
Registration Date | Tuesday, September 26, 2006 |
Attorney | Mark H. Tidman |
Domestic Representative | Piper Marbury Rudrick & Wolfe |
Correspondent
Ann K. Ford, Esq.
DLA PIPER RUDNICK GRAY CARY US LLP
1200 Nineteenth Street, NW
Washington DC 20036-2412
DLA PIPER RUDNICK GRAY CARY US LLP
1200 Nineteenth Street, NW
Washington DC 20036-2412
Case File Statements
Disclaimer with Predetermined Text | "Bioscience" |
---|---|
Goods & Services | pharmaceutical preparations for medical diagnosis, namely, for the diagnosis of pregnancy; sanitary preparations, namely, tampons used for delivering pharmaceutical preparations to the female reproductive tract and tampons designed to reduce the chance of infection of the female reproductive tract; sanitary pads; sanitary napkins; dietetic products for medical use, namely, dietary supplements and food for medical restricted diets; diagnostic kits consisting primarily of medical diagnostic reagents and preparations for reproductive health uses, semen analysis, testing sperm fertilization capability, hormone level analysis for testing the presence and level of Luteneising Hormone (LH), Follicle Stimulating Hormone (FSH), Beta-Oestradiol, Prolactin, Progesterone, Human Chorionic Gonadotrophin (hCG) and Testosterone, to detect genital infections, to test for antibodies to various organisms, to detect markers of pre-term labor, pregnancy complications, miscarriage and implantation failure, to detect antiphospholipids, protein S deficiency, lupus anti-coagulant and factor V Leiden mutation, to detect markers of female fertility, to detect DAZL heterozygous mutation and associated biochemical markers such as testosterone for the analysis of DNA, RNA for the detection of disease or predisposition associated with reproduction, for the analysis of protein or other biochemical markers of disease or predisposition of disease, to detect biochemical markers which indicate disease or predisposition to disease; oral contraceptives; contraceptive foams |
Goods & Services | diagnostic kits consisting primarily of dipsticks, litmus paper, test-tubes, pipettes, stylets for drawing blood samples, plastic containers, slides, syringes, needles, spatulas and non-invasive devices, and medical diagnostic reagents and preparations for obtaining and testing biological samples for reproductive health uses, semen analysis, testing sperm fertilization capability, hormone level analysis for testing the presence and level of Luteneising Hormone (LH), Follicle Stimulating Hormone (FSH), Beta-Qestradiol, Prolactin, Progesterone, Human ChorionicGonadotrophin (hCG) and Testosterone, to detect genital infections, to test for antibodies to various organisms, to detect markers of pre-term labor, pregnancy complications, miscarriage and implantation failure, to detect antiphospholipids, protein S deficiency, lupus anti-coagulant and factor V Leiden mutation, to detect markers of female fertility, to detect DAZL heterozygous mutation and associated biochemical markers such as testosterone for the analysis of DNA, RNA for the detection of disease or predisposition associated with reproduction, for the analysis of protein or other biochemical markers of disease or predisposition of disease, to detect biochemical markers which indicate disease or predisposition to disease; surgical and medical apparatus, namely, dipsticks, litmus paper, test-tubes, pipettes, stylets for drawing blood samples, plastic containers, slides, syringes, needles, spatulas and non-invasive devices for obtaining and testing biological samples; diaphragms for contraception; coils for contraception; protective sheaths for contraception |
Goods & Services | Medical Assistance, Namely the Provision of Medical Support Staff to Clinics and Medical Practices for the Screening of Patients, Auditing and Maintenance of Records, and Consultation Regarding Diagnoses and Treatment Options; Nursing Services, Namely Providing Nursing Staff to Doctors, Clinics, Hospitals and Medical Practices |
Goods & Services | Scientific research and development of new products for others; technical consultation and research in the fields of health, wellbeing, nursing, medicine and healthcare |
Goods & Services | Healthcare services; medical clinics; midwife services; provision of information relating to health, wellbeing, nursing, medicine and healthcare via the Internet |
Pseudo Mark | Ardana Biology Science |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 2 — Sec. 8 – Entire Registration |
Status Date | Friday, May 3, 2013 |
Primary Code | 005 |
International Class Codes |
010
|
---|---|
U.S. Class Codes | 026, 039, 044 |
Status | 2 — Sec. 8 – Entire Registration |
Status Date | Friday, May 3, 2013 |
Primary Code | 010 |
International Class Codes |
035
|
---|---|
U.S. Class Codes | 100, 101, 102 |
Status | 2 — Sec. 8 – Entire Registration |
Status Date | Friday, May 3, 2013 |
Primary Code | 035 |
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 2 — Sec. 8 – Entire Registration |
Status Date | Friday, May 3, 2013 |
Primary Code | 042 |
International Class Codes |
044
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 2 — Sec. 8 – Entire Registration |
Status Date | Friday, May 3, 2013 |
Primary Code | 044 |
Trademark Timeline
-
Dec 11 2000Trademark application filed with USPTO
-
Apr 04 2001Assigned To Examiner
-
Apr 11 2001Non-Final Action Mailed
-
Oct 11 2001Correspondence Received In Law Office
-
Oct 15 2001Unresponsive/duplicate Paper Received
-
Feb 05 2002Letter of Suspension Mailed
-
Jul 17 2002Teas Change of Correspondence Received
-
Sep 23 2002Inquiry As To Suspension Mailed
-
Mar 21 2003Correspondence Received In Law Office
-
Mar 21 2003Paper Received
-
Apr 25 2003Non-Final Action Mailed
-
Oct 24 2003Correspondence Received In Law Office
-
Oct 24 2003Teas Response To Office Action Received
-
Nov 09 2003Case File In Ticrs
-
Mar 08 2004Non-Final Action Mailed
-
Aug 24 2004Correspondence Received In Law Office
-
Aug 24 2004Teas Response To Office Action Received
-
Sep 29 2004Approved For Pub - Principal Register
-
Sep 29 2004Amendment From Applicant Entered
-
Oct 04 2004Assigned To Lie
-
Dec 17 2004Law Office Publication Review Completed
-
Jan 25 2005Approved For Pub - Principal Register
-
Jan 25 2005Examiners Amendment E-Mailed
-
Jan 25 2005Examiners Amendment -Written
-
Jan 25 2005Previous Allowance Count Withdrawn
-
Jan 31 2005Assigned To Lie
-
Feb 14 2005Assigned To Lie
-
Feb 16 2005Law Office Publication Review Completed
-
May 16 2005Withdrawn Before Publication
-
May 31 2005Examiners Amendment E-Mailed
-
May 31 2005Examiners Amendment -Written
-
May 31 2005Previous Allowance Count Withdrawn
-
Jun 01 2005Assigned To Lie
-
Jun 09 2005Approved For Pub - Principal Register
-
Jun 09 2005Examiner's Amendment Entered
-
Jul 18 2005Law Office Publication Review Completed
-
Aug 19 2005Teas Change of Correspondence Received
-
Sep 28 2005Notice of Publication
-
Oct 18 2005Published For Opposition
-
Jan 10 2006Noa Mailed - Sou Required From Applicant
-
May 02 2006Fax Received
-
May 24 2006Notice of Allowance Correction Entered
-
Jul 07 2006Notice of Allowance Cancelled
-
Jul 07 2006Teas Delete 1(B) Basis Received
-
Jul 19 20061(B) Basis Deleted; Proceed To Registration
-
Sep 26 2006Registered-Principal Register
-
Sep 26 2006Trademark officially registered with the USPTO
-
May 03 2013Cancelled Sec. 8 (6-Yr)